| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Bárbara Peleteiro | Q37841116 |
| Vicente Martinez Vizcaino | Q42825682 | ||
| Celia Álvarez-Bueno | Q88254541 | ||
| Iván Cavero-Redondo | Q89509960 | ||
| P2093 | author name string | Fernando Rodriguez-Artalejo | |
| P2860 | cites work | International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes | Q24642456 |
| Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis | Q26860467 | ||
| Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis | Q27021243 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation | Q28088806 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
| Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association | Q30434464 | ||
| 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q34154032 | ||
| Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis | Q34307827 | ||
| Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization | Q34448710 | ||
| The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies | Q35025208 | ||
| Follow-up report on the diagnosis of diabetes mellitus | Q35567871 | ||
| Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review | Q35772791 | ||
| The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis | Q36001658 | ||
| HbA1c and Risks of All-Cause and Cause-Specific Death in Subjects without Known Diabetes: A Dose-Response Meta-Analysis of Prospective Cohort Studies | Q36764797 | ||
| Glycosylated haemoglobin as a predictor of cardiovascular events and mortality: a protocol for a systematic review and meta-analysis. | Q37100780 | ||
| 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult | Q38076875 | ||
| Assessing bias in studies of prognostic factors | Q38082694 | ||
| (2) Classification and diagnosis of diabetes | Q38299539 | ||
| Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis | Q38572028 | ||
| Effects of biological age on the associations of blood pressure with cardiovascular and non-cardiovascular mortality in old age: A population-based study. | Q39621967 | ||
| Random-effects model for meta-analysis of clinical trials: an update | Q44449763 | ||
| European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice | Q49154329 | ||
| Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. | Q51922378 | ||
| Explaining heterogeneity in meta-analysis: a comparison of methods. | Q52141807 | ||
| Cohort studies: prospective versus retrospective. | Q53059638 | ||
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies | Q56529982 | ||
| Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
| Dichotomizing continuous predictors in multiple regression: a bad idea | Q81336757 | ||
| Age, sex, and secondary prevention of ischaemic heart disease in everyday practice | Q87000977 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | carbohydrate | Q11358 |
| cardiovascular disease | Q389735 | ||
| blood proteins | Q425056 | ||
| meta-analysis | Q815382 | ||
| heme protein | Q902628 | ||
| risk factor | Q1475848 | ||
| type 2 diabetes | Q3025883 | ||
| glycated hemoglobin A | Q78346845 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e015949 | |
| P577 | publication date | 2017-07-31 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis | |
| P478 | volume | 7 |
| Q57822229 | Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk |
| Q64111019 | Association between Glycated Hemoglobin with the Levels of Serum Proinflammatory Cytokines and Antioxidants in Patients with Type 2 Diabetes Mellitus in Universitas Sumatera Utara Hospital |
| Q60044841 | Association between random glucose and all-cause mortality: findings from the mortality follow-up of the German National Health Interview and Examination Survey 1998 |
| Q92082815 | Association of Prenatal and Perinatal Exposures to Particulate Matter With Changes in Hemoglobin A1c Levels in Children Aged 4 to 6 Years |
| Q64084596 | Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes |
| Q48242046 | Diabetes mellitus is associated with increased elastin fiber loss in ligamentum flavum of patients with lumbar spinal canal stenosis: results of a pilot histological study |
| Q89759303 | Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes |
| Q101043636 | Improved estimation of glycated hemoglobin with continuous glucose monitoring and past glycated hemoglobin data |
| Q92216594 | Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes |
| Q91726883 | Metabolic Syndrome Including Glycated Hemoglobin A1c in Adults: Is It Time to Change? |
| Q64112606 | Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies |
| Q97425035 | Telehealth and indigenous populations around the world: a systematic review on current modalities for physical and mental health |
| Q49907998 | The Effect of Physical Activity Interventions on Glycosylated Haemoglobin (HbA1c) in Non-diabetic Populations: A Systematic Review and Meta-analysis |
| Q94469063 | The intersecting role of glycaemia and cardiac function in the development of heart failure among patients with type 2 diabetes mellitus after an acute coronary syndrome |
| Q94665718 | Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin |
| Q58085098 | Vitamin D status of tuberculosis patients with diabetes mellitus in different economic areas and associated factors in China |
Search more.